share_log

東証グロース市場250指数先物概況:米つなぎ予算延長法案否決で売り優勢

Overview of the Tokyo Stock Exchange Growth Market 250 Index Futures: Selling is dominant due to the rejection of the U.S. budget extension bill.

Fisco Japan ·  Dec 20 15:30

On December 20, the TSE Growth Market 250 Index Futures closed at 615 points, down 6 points from the previous trading day. The high was 625 points, the low was 613 points, and the intraday trading volume was 2,837 contracts. The Dow Inc average in the US market rebounded for the first time in 11 days on the 19th. Following the Federal Open Market Committee (FOMC) indicating a slowdown in the pace of additional interest rate cuts, there was a buying movement due to the view that the previous day's sharp drop was overdone. The domestic GDP for the July-September period announced in the morning was revised upwards, and the number of new insurance applicants also decreased, indicating an expansion of economic activity which led to a rise in long-term interest rates, becoming a drag on the market and causing stagnation. As selling became dominant toward the close, the Nasdaq turned downward. Today's TSE Growth Market 250 Index Futures started at 624 points, up 3 points from the previous trading day. Following the Dow Inc's rebound, buying was dominant in the morning, but it quickly lost momentum. The US House of Representatives voted against a newly proposed continuing resolution budget extension bill by the Republican Party, leading to a risk-off sentiment and the overall Japanese market being dominated by selling. On the other hand, the core consumer price index for November matched consensus, and some market participants anticipated that interest rates would remain unchanged at the January monetary policy meeting, which limited the downside, and trading concluded at 615 points. Among the leading stocks in the TSE Growth Market, companies like GNI (2160) and Cover (5253) experienced declines.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment